{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} An Introduction to Gender-Affirming Hormone Therapy for Transgender and Gender-Nonbinary Patients

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain gender incongruence and cultural competence.
  2. Describe the informed consent model (ICM) of care.
  3. Select appropriate GAHT treatments and diagnostic testing for monitoring use in case scenarios.

Learning Outcomes

Seventy-five percent of participants will be able to demonstrate an increase in knowledge regarding gender-affirming hormone therapy (GAHT) for transgender and gender-nonbinary (TGNB) patients by achieving a posttest score of 70% or greater.
Price: $24.95

Credits:

  • ANCC 2.5 CH / 2.0 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: NP0322A
Published: Mar 2022
Expires: 3/7/2025
Required Passing Score: 8/10 (80%)
Authors: Miles S. Harris, MSN, FNP-BC; B. Ashby Goodrum, MSN, FNP-BC; Chance N. Krempasky, MSN, FNP-BC, WHNP-BC